Effects of ID-HWS1000 on the Perception of Bowel Activity and Microbiome in Subjects with Functional Constipation: A Randomized, Double-Blind Placebo-Controlled Study

被引:16
|
作者
Kim, Min Cheol [1 ]
Lee, Sunghee [2 ]
Park, Jin Kyung [1 ]
Park, Jongmi [1 ]
Lee, Donghun [2 ]
Park, Jaewan [2 ]
Kim, Byung-Yong [3 ]
Cho, Min Seok [3 ]
Kim, Tae-Yoon [2 ]
Park, Ha Young [1 ]
Park, Ju Hyun [4 ,5 ]
Bok, Min Kyung [4 ,5 ]
Lim, Hyunjung [4 ,5 ]
机构
[1] ILDONG Pharmaceut Co Ltd, Hwaseong, South Korea
[2] ILDONG Pharmaceut Co Ltd, Res Lab, Hwaseong, South Korea
[3] ChunLab Inc, Microbiome Res Ctr, Seoul, South Korea
[4] Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, South Korea
[5] Kyung Hee Univ, Res Inst Med Nutr, Yongin, South Korea
关键词
bowel movements; functional constipation; gut microbiome; prebiotics; probiotics; CHRONIC IDIOPATHIC CONSTIPATION; GUT MICROBIOME; PROBIOTICS; PREBIOTICS; SYMPTOMS; SEARCH;
D O I
10.1089/jmf.2020.4746
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
During constipation, indigestible foods, such as probiotics, prebiotics, and dietary fiber, may improve the bowel environment and activity. In this randomized, double-blind, and placebo-controlled study, the effects of ID-HWS1000, composed of Lactobacillus and Bifidobacterium species, xylooligosaccharide, and dietary fiber, were evaluated to determine whether it improves the perception of bowel activity or cause changes in the gut microbiome. Thirty Korean adults with "functional constipation" according to the Rome III criteria were randomly assigned to the following groups: 20 in the ID-HWS1000 group and 10 in the placebo group. ID-HWS1000 or the placebo was consumed by the participants for 4 weeks. To assess the changes in the perception of bowel activity, clinical data and gut microbiome analyses were conducted before and after the experiment. There were significant differences between the groups in the response to 9 of the 12 survey questions (the number and duration of bowel movements, amount of feces, number of irritant bowel movements, number of times bowel movements felt incomplete, shape of the feces, amount of gas in the gut, discomfort after defecation, and discomfort owing to constipation) (P < .05). There was a decrease in the proportion of Firmicutes (Ruminococcaceae and Lachnospiraceae) and an increase in Bacteroidetes (Bacteroidaceae) (P < .05). Moreover, ID-HWS1000 directly improved the discomfort associated with bowel movements, decreased the proportion of Lachnospiraceae, and increased the proportion of Bacteroidaceae. These results confirmed that ID-HWS1000 improves the perception of bowel activity and exerts positive changes in individuals with functional constipation.
引用
收藏
页码:883 / 893
页数:11
相关论文
共 50 条
  • [21] Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial
    Kwon, Hyeji
    Nam, Eoun Ho
    Kim, Hayoung
    Jo, Haneul
    Bang, Won Yeong
    Lee, Minjee
    Shin, Hyeonmin
    Kim, Dana
    Kim, Jeongho
    Kim, Hyejin
    Lee, Jongkyun
    Jung, Young Hoon
    Yang, Jungwoo
    Won, Daeyoun David
    Shin, Minhye
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial
    Yoon, Jun Sik
    Sohn, Won
    Lee, Oh Young
    Lee, Sang Pyo
    Lee, Kang Nyeong
    Jun, Dae Won
    Lee, Hang Lak
    Yoon, Byung Chul
    Choi, Ho Soon
    Chung, Won-Seok
    Seo, Jae-Gu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 52 - 59
  • [23] Effects of 1-kestose on microbiome changes caused by vonoprazan: a randomized, double-blind, placebo-controlled pilot study
    Furune, Satoshi
    Suzuki, Takahiro
    Honda, Takashi
    Yamamoto, Kenta
    Furukawa, Kazuhiro
    Nakamura, Masanao
    Ishigami, Masatoshi
    Kinoshita, Fumie
    Kadota, Yoshihiro
    Tochio, Takumi
    Shimomura, Yoshiharu
    Hirooka, Yoshiki
    Fujishiro, Mitsuhiro
    Kawashima, Hiroki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (03) : 480 - 488
  • [24] Protocol of a randomized, double-blind, placebo-controlled study of the effect of probiotics on the gut microbiome of patients with gastro-oesophageal reflux disease treated with rabeprazole
    Liu, Wenjun
    Xie, Yong
    Li, Yingmeng
    Zheng, Longjin
    Xiao, Qiuping
    Zhou, Xu
    Li, Qiong
    Yang, Ni
    Zuo, Kexuan
    Xu, Tielong
    Lu, Nong-Hua
    Zhang, Heping
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [25] Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trial
    Grat, Michal
    Wronka, Karolina M.
    Lewandowski, Zbigniew
    Grat, Karolina
    Krasnodebski, Maciej
    Stypulkowski, Jan
    Holowko, Waclaw
    Masior, Lukasz
    Kosinska, Irena
    Wasilewicz, Michal
    Raszeja-Wyszomirska, Joanna
    Rejowski, Slawomir
    Bik, Emil
    Patkowski, Waldemar
    Krawczyk, Marek
    CLINICAL NUTRITION, 2017, 36 (06) : 1530 - 1539
  • [26] Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of a Randomized Double-Blind Placebo-Controlled Trial
    Gasiorowska, Anita
    Romanowski, Marek
    Walecka-Kapica, Ewa
    Kaczka, Aleksandra
    Chojnacki, Cezary
    Padysz, Milena
    Siedlecka, Marta
    Bierla, Joanna B.
    Steinert, Robert E.
    Cukrowska, Bozena
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [27] Treatment of functional dyspepsia with sertraline: A double-blind randomized placebo-controlled pilot study
    Tan, Victoria P. Y.
    Cheung, Tin K.
    Wong, Wai M.
    Pang, Roberta
    Wong, Benjamin C. Y.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (42) : 6127 - 6133
  • [28] A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation
    Mueller-Lissner, S.
    Rykx, A.
    Kerstens, R.
    Vandeplassche, L.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 (09) : 991 - +
  • [29] Effect of Portulaca Oleracea L. extract on functional constipation: A randomized, double-blind, placebo-controlled trial
    Bang, Ki Bae
    Choi, Jung Ho
    Park, Jee Hun
    Lee, Seong
    Rho, Mun-Chual
    Lee, Seung W.
    Lee, Soyoung
    Shin, Jeong Eun
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2022, 28 (04) : 296 - +
  • [30] Effects of synbiotic supplementation on the components of metabolic syndrome in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
    Basafa-Roodi, Poorya
    Jazayeri, Shima
    Hadi, Fatemeh
    Paghaleh, Somaye Jamali
    Khosravi-darani, Kianush
    Malakouti, Seyed Kazem
    BMC PSYCHIATRY, 2024, 24 (01)